Cross-source evidence timeline

Nesiritide research timeline

Follow 56 selected, directly cited source records from December 23, 1998 through November 8, 2026. This timeline joins source lanes for navigation; it does not infer that one record confirms another.

56Selected records
18Source years
3Evidence lanes
November 8, 2026Latest source date

Source year

2026

2 records
  1. Literature metadata

    Nesiritide in acute decompensated heart failure: current status and future perspectives.↗

    PubMed lists PMID 18953274 in Reviews in cardiovascular medicine as Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2008 Summer (source-text precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Nesiritide: the clinical experience.↗

    PubMed lists PMID 18629384 in The Canadian journal of cardiology as Journal Article, Review, with publication-date metadata of 2008-07 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2025

1 record
  1. Literature metadata

    Nesiritide following maze and mitral valve surgery.↗

    PubMed lists PMID 18928481 in Journal of cardiac surgery as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2008 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2021

1 record
  1. Regulatory

    Federal Register notice 2021-00118↗

    The Federal Register published notice 2021-00118, attributed to FDA and its parent HHS department, on 2021-01-08. Its official title is “Determination That ARALEN (Chloroquine Phosphate) Oral Tablets, 500 Milligrams, and Other Drug Products Were Not Withdrawn From Sale for Reasons of Safety or Effectiveness,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.↗

Source year

2020

2 records
  1. Literature metadata

    Nesiritide in patients with acute myocardial infarction and heart failure: a meta-analysis.↗

    PubMed lists PMID 31948318 in The Journal of international medical research as Journal Article, Meta-Analysis, with publication-date metadata of 2020-01 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Regulatory

    Federal Register notice 2020-10367↗

    The Federal Register published notice 2020-10367, attributed to FDA and its parent HHS department, on 2020-05-14. Its official title is “Janssen Pharmaceuticals, Inc., et al.; Withdrawal of Approval of 16 New Drug Applications,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.↗

Source year

2019

7 records
  1. Literature metadata

    Practical application of nonrandomized research to patient care: a case study of nesiritide.↗

    PubMed lists PMID 17192168 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2007-01 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Controversy and conflict in the treatment of acute decompensated heart failure: nesiritide as evidence-based treatment.↗

    PubMed lists PMID 17461695 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2007-05 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Decompensated heart failure: is there a role for the outpatient use of nesiritide?↗

    PubMed lists PMID 15470300 in Congestive heart failure (Greenwich, Conn.) as Journal Article, Review, with publication-date metadata of 2004 Sep-Oct (source-text precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    The use of recombinant human B-type natriuretic peptide (nesiritide) in the management of acute decompensated heart failure.↗

    PubMed lists PMID 15605677 in International journal of clinical practice as Journal Article, Research Support, Non-U.S. Gov't, Review, with publication-date metadata of 2004-11 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Nesiritide for the treatment of congestive heart failure.↗

    PubMed lists PMID 15102572 in Expert opinion on pharmacotherapy as Journal Article, Review, with publication-date metadata of 2004-04 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    Pharmacoeconomic modeling of nesiritide versus dobutamine for decompensated heart failure.↗

    PubMed lists PMID 16509026 in Pharmacotherapy as Comparative Study, Journal Article, Randomized Controlled Trial, with publication-date metadata of 2006-01 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Intermittent nesiritide therapy in outpatients with chronic heart failure.↗

    PubMed lists PMID 15700894 in American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists as Clinical Trial, Comparative Study, Journal Article, with publication-date metadata of 2005-01-15 (day precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2018

4 records
  1. Literature metadata

    Levosimendan and nesiritide as a combination therapy in patients with acute heart failure.↗

    PubMed lists PMID 25853935 in The American journal of the medical sciences as Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, with publication-date metadata of 2015-05 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT01544998↗

    PeptideScanner retained ClinicalTrials.gov record NCT01544998 at 2026-11-16T01:39:41.882Z. Its registry update date was 2018-03-22, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT01977859↗

    PeptideScanner retained ClinicalTrials.gov record NCT01977859 at 2026-11-16T01:39:41.882Z. Its registry update date was 2018-02-14, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT02608996↗

    PeptideScanner retained ClinicalTrials.gov record NCT02608996 at 2026-11-16T01:39:41.882Z. Its registry update date was 2018-01-03, and PeptideScanner's reviewed identity mapping was nesiritide.↗

Source year

2015

4 records
  1. Clinical trials

    ClinicalTrials.gov record NCT01413542↗

    PeptideScanner retained ClinicalTrials.gov record NCT01413542 at 2026-11-16T01:39:41.882Z. Its registry update date was 2015-11-04, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00205426↗

    PeptideScanner retained ClinicalTrials.gov record NCT00205426 at 2026-11-16T01:39:41.882Z. Its registry update date was 2015-10-14, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00405548↗

    PeptideScanner retained ClinicalTrials.gov record NCT00405548 at 2026-11-16T01:39:41.882Z. Its registry update date was 2015-07-01, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  4. Literature metadata

    Natriuretic peptides for the treatment of acute heart failure: a focus on nesiritide in recent clinical trials.↗

    PubMed lists PMID 26028173 in Expert review of cardiovascular therapy as Journal Article, Review, with publication-date metadata of 2015-05-31 (day precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2014

6 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00573144↗

    PeptideScanner retained ClinicalTrials.gov record NCT00573144 at 2026-11-16T01:39:41.882Z. Its registry update date was 2014-09-09, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT01132846↗

    PeptideScanner retained ClinicalTrials.gov record NCT01132846 at 2026-11-16T01:39:41.882Z. Its registry update date was 2014-08-21, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  3. Literature metadata

    The role of nesiritide in heart failure.↗

    PubMed lists PMID 19538002 in Expert opinion on drug metabolism & toxicology as Journal Article, Review, with publication-date metadata of 2009-07 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT01440881↗

    PeptideScanner retained ClinicalTrials.gov record NCT01440881 at 2026-11-16T01:39:41.882Z. Its registry update date was 2014-06-06, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT00405639↗

    PeptideScanner retained ClinicalTrials.gov record NCT00405639 at 2026-11-16T01:39:41.882Z. Its registry update date was 2014-03-17, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT00813202↗

    PeptideScanner retained ClinicalTrials.gov record NCT00813202 at 2026-11-16T01:39:41.882Z. Its registry update date was 2014-02-28, and PeptideScanner's reviewed identity mapping was nesiritide.↗

Source year

2013

6 records
  1. Literature metadata

    Critical review and recommendations for nesiritide use in the emergency department.↗

    PubMed lists PMID 16183453 in The Journal of emergency medicine as Journal Article, Review, with publication-date metadata of 2005-10 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  2. Literature metadata

    Nesiritide: trials and tribulations.↗

    PubMed lists PMID 17056828 in Journal of cardiovascular pharmacology and therapeutics as Journal Article, Review, with publication-date metadata of 2006-09 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Nesiritide compared with milrinone for cardiac surgery.↗

    PubMed lists PMID 17327288 in The Annals of pharmacotherapy as Comparative Study, Journal Article, Review, with publication-date metadata of 2007-02-27 (day precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT00119691↗

    PeptideScanner retained ClinicalTrials.gov record NCT00119691 at 2026-11-16T01:39:41.882Z. Its registry update date was 2013-09-12, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT00842023↗

    PeptideScanner retained ClinicalTrials.gov record NCT00842023 at 2026-11-16T01:39:41.882Z. Its registry update date was 2013-08-30, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT00475852↗

    PeptideScanner retained ClinicalTrials.gov record NCT00475852 at 2026-11-16T01:39:41.882Z. Its registry update date was 2013-03-08, and PeptideScanner's reviewed identity mapping was nesiritide.↗

Source year

2012

2 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00252187↗

    PeptideScanner retained ClinicalTrials.gov record NCT00252187 at 2026-11-16T01:39:41.882Z. Its registry update date was 2012-12-20, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00387621↗

    PeptideScanner retained ClinicalTrials.gov record NCT00387621 at 2026-11-16T01:39:41.882Z. Its registry update date was 2012-05-17, and PeptideScanner's reviewed identity mapping was nesiritide.↗

Source year

2011

7 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00270361↗

    PeptideScanner retained ClinicalTrials.gov record NCT00270361 at 2026-11-16T01:39:41.882Z. Its registry update date was 2011-07-26, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  2. Clinical trials

    ClinicalTrials.gov record NCT00270374↗

    PeptideScanner retained ClinicalTrials.gov record NCT00270374 at 2026-11-16T01:39:41.882Z. Its registry update date was 2011-06-10, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  3. Clinical trials

    ClinicalTrials.gov record NCT00270400↗

    PeptideScanner retained ClinicalTrials.gov record NCT00270400 at 2026-11-16T01:39:41.882Z. Its registry update date was 2011-06-10, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  4. Clinical trials

    ClinicalTrials.gov record NCT00288730↗

    PeptideScanner retained ClinicalTrials.gov record NCT00288730 at 2026-11-16T01:39:41.882Z. Its registry update date was 2011-06-10, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  5. Clinical trials

    ClinicalTrials.gov record NCT00091520↗

    PeptideScanner retained ClinicalTrials.gov record NCT00091520 at 2026-11-16T01:39:41.882Z. Its registry update date was 2011-05-20, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  6. Clinical trials

    ClinicalTrials.gov record NCT00653042↗

    PeptideScanner retained ClinicalTrials.gov record NCT00653042 at 2026-11-16T01:39:41.882Z. Its registry update date was 2011-05-19, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  7. Clinical trials

    ClinicalTrials.gov record NCT00271557↗

    PeptideScanner retained ClinicalTrials.gov record NCT00271557 at 2026-11-16T01:39:41.882Z. Its registry update date was 2011-03-04, and PeptideScanner's reviewed identity mapping was nesiritide.↗

Source year

2010

1 record
  1. Literature metadata

    Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.↗

    PubMed lists PMID 17461696 in Pharmacotherapy as Comment, Journal Article, Review, with publication-date metadata of 2007-05 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2009

1 record
  1. Clinical trials

    ClinicalTrials.gov record NCT00170183↗

    PeptideScanner retained ClinicalTrials.gov record NCT00170183 at 2026-11-16T01:39:41.882Z. Its registry update date was 2009-11-16, and PeptideScanner's reviewed identity mapping was nesiritide.↗

Source year

2008

1 record
  1. Literature metadata

    Nesiritide in the initial management of acute decompensated congestive heart failure.↗

    PubMed lists PMID 18833867 in Connecticut medicine as Journal Article, Randomized Controlled Trial, with publication-date metadata of 2008-10 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2007

7 records
  1. Clinical trials

    ClinicalTrials.gov record NCT00559338↗

    PeptideScanner retained ClinicalTrials.gov record NCT00559338 at 2026-11-16T01:39:41.882Z. Its registry update date was 2007-11-16, and PeptideScanner's reviewed identity mapping was nesiritide.↗

  2. Literature metadata

    Is there a use for nesiritide in pediatric patients?↗

    PubMed lists PMID 15154998 in Journal of intensive care medicine as Editorial, Review, with publication-date metadata of 2004 May-Jun (source-text precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  3. Literature metadata

    Nesiritide for the treatment of decompensated heart failure.↗

    PubMed lists PMID 15500426 in Expert review of cardiovascular therapy as Comparative Study, Journal Article, Review, with publication-date metadata of 2004-11 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  4. Literature metadata

    Nesiritide: past, present, and future.↗

    PubMed lists PMID 16333235 in Minerva cardioangiologica as Comparative Study, Journal Article, Review, with publication-date metadata of 2005-12 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  5. Literature metadata

    Nesiritide: the latest drug for treating heart failure.↗

    PubMed lists PMID 16443809 in Critical care nurse as Case Reports, Journal Article, Review, with publication-date metadata of 2006-02 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  6. Literature metadata

    [Nesiritide in heart failure: commercial success or therapeutic advance?].↗

    PubMed lists PMID 16503047 in Revue medicale suisse as English Abstract, Journal Article, Review, with publication-date metadata of 2006-01-25 (day precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

  7. Literature metadata

    Nesiritide: harmful or harmless?↗

    PubMed lists PMID 16999657 in Pharmacotherapy as Journal Article, Review, with publication-date metadata of 2006-10 (month precision). PeptideScanner associated the retained record with the identity slug nesiritide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.↗

Source year

2006

1 record
  1. Regulatory

    Federal Register notice E6-16091↗

    The Federal Register published notice E6-16091, attributed to FDA and its parent HHS department, on 2006-10-02. Its official title is “Determination of Regulatory Review Period for Purposes of Patent Extension; NATRECOR,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.↗

Source year

2001

2 records
  1. Regulatory

    Drugs@FDA application NDA020920↗

    The official Drugs@FDA dataset lists original submission 1 for NDA 020920 with status AP dated 2001-08-10, and names nesiritide among the application record's active ingredients.↗

  2. Regulatory

    Federal Register notice 01-10450↗

    The Federal Register published notice 01-10450, attributed to FDA and its parent HHS department, on 2001-04-27. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.↗

Source year

1998

1 record
  1. Regulatory

    Federal Register notice 98-33915↗

    The Federal Register published notice 98-33915, attributed to FDA and its parent HHS department, on 1998-12-23. Its official title is “Cardiovascular and Renal Drugs Advisory Committee; Notice of Meeting,” and PeptideScanner's exact reviewed identity mapping connects the document to Nesiritide.↗